Pelthos Therapeutics Inc. announced that CEO Scott Plesha and CFO Francis Knuettel II will present at the Wells Fargo 2025 Healthcare Conference on September 3, 2025, discussing their product pipeline and the launch of ZELSUVMI. This event is significant for investors as it highlights key business developments.